Caravel Oculus Pty Ltd
1 clinical trials · Sponsor
◉ Watch Caravel Oculus Pty Ltd
| Record | Firm | Date |
|---|---|---|
| A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery (NCT07694375) | Caravel Oculus Pty Ltd | 2026-07-28 |
Track Caravel Oculus Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.